Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | August 11, 2022 08:15am

 

Gainers

  • AcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 61.1% to $0.38 during Thursday's pre-market session. The company's market cap stands at $55.7 million. The company's, Q2 earnings came out today.
  • T2 Biosystems (NASDAQ:TTOO) shares rose 39.05% to $0.22. The market value of their outstanding shares is at $37.7 million.
  • aTyr Pharma (NASDAQ:LIFE) stock increased by 35.12% to $5.04. The company's market cap stands at $141.4 million.
  • Kala Pharmaceuticals (NASDAQ:KALA) stock moved upwards by 35.05% to $0.47. The company's market cap stands at $34.1 million. As per the news, the Q2 earnings report came out today.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock increased by 23.3% to $1.64. The market value of their outstanding shares is at $16.3 million. The company's, Q2 earnings came out yesterday.
  • Cingulate (NASDAQ:CING) shares moved upwards by 19.39% to $1.97.

Losers

  • Athenex (NASDAQ:ATNX) stock declined by 36.9% to $0.7 during Thursday's pre-market session. The company's market cap stands at $85.1 million.
  • Hyperfine (NASDAQ:HYPR) stock fell 19.48% to $1.5. The market value of their outstanding shares is at $105.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Invitae (NYSE:NVTA) stock declined by 19.01% to $6.99. The company's market cap stands at $1.6 billion. The company's, Q2 earnings came out 2 days ago.
  • Landos Biopharma (NASDAQ:LABP) shares fell 11.39% to $1.09. The company's market cap stands at $43.8 million.
  • ChromaDex (NASDAQ:CDXC) shares declined by 10.2% to $1.85. The company's market cap stands at $126.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Sanofi (NASDAQ:SNY) stock decreased by 9.45% to $40.93. The market value of their outstanding shares is at $102.3 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACRX ATNX CDXC CING CYCC HYPR KALA LABP LIFE NVTA SNY TTOO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist